Advertisement

FDA delay raises slim hope for muscular dystrophy drug

By Associated Press  |  May 25, 2016

The Food and Drug Administration will take more time to review a highly contested drug for muscular dystrophy that has become a flashpoint in the debate over patient access to experimental medicine.

Editorial: What's a new cancer drug worth?

Editorial: What's a new cancer drug worth?

By Merrill Goozner  |  May 21, 2016

While the latest cancer drugs emerging from drug and biotechnology company labs can come with hefty price tags, they don't necessarily have a lot of evidence showing they actually work.

FDA again delays generic labeling rule

By Adam Rubenfire  |  May 20, 2016

For the third time, the FDA has delayed a rule requiring generic-drug companies to update product labels if they receive new safety information.

Colombia battles world's biggest drugmaker over cancer drug

By Associated Press  |  May 18, 2016

Colombia's government is giving pharmaceutical giant Novartis a few weeks to lower prices on a popular cancer drug or see its monopoly on production of the medicine broken and competition thrown open to generic rivals.

FDA OKs immunotherapy drugs for bladder, blood cancers

By Associated Press  |  May 18, 2016

U.S. regulators have approved the first drug for bladder cancer that harnesses the body's immune system. It is the first advance in decades against the most common type of bladder cancer, one which almost always kills patients within months.

Pfizer to buy Anacor Pharmaceuticals in $5.2B deal

By Associated Press  |  May 16, 2016

Pfizer will acquire Anacor Pharmaceuticals in a deal valued at about $5.2 billion. Anacor's topical treatment for eczema, called crisaborole, is currently under review by the FDA. If approved, Pfizer said it believes peak year sales could reach or exceed $2 billion.

Billionaire gives $200 million to USC for cancer research

By Associated Press  |  May 12, 2016

Oracle founder Larry Ellison has donated $200 million to the University of Southern California to fund a cancer research center, matching the largest single donation ever received by the school.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.